Eric Hyllengren
Equibles does not estimate personal net worth.
Get an email with a short summary when Tenaya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TNYA alertsAbout Eric Hyllengren
Eric Hyllengren is recorded as CFO at Tenaya Therapeutics, Inc. (TNYA) since July 13, 2026. Tenaya Therapeutics, Inc. reported in an 8-K filed June 29, 2026 that Eric Hyllengren was appointed Chief Financial Officer, effective July 13, 2026. Tenaya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tenaya Therapeutics, Inc. includes Faraz Ali (CEO, CFO and Board Member), Chihiro Saito (Chief Accounting Officer), Tomohiro Higa (Chief Accounting Officer) and 7 others.
“On June 29, 2026, Tenaya Therapeutics, Inc. (the “Company”) announced that Eric Hyllengren, M.B.A., will join the Company as Chief Financial Officer on July 13, 2026 (the “Commencement Date”), and in such capacity, will serve as the Company’s Principal Financial Officer and Principal Accounting Officer beginning on the Commencement Date.”
Affiliation history
-
Current
2026-07-13–present
Company network
Leadership on record at Tenaya Therapeutics, Inc.
- Faraz Ali CEO, CFO, Board Member
- Chihiro Saito Chief Accounting Officer
- Tomohiro Higa Chief Accounting Officer
- Amy Burroughs Board Member
- Catherine Stehman-Breen Board Member
- Continuing Directors Board Member
- Deepak Srivastava Board Member
- Jeffrey T. Walsh Board Member
- June Lee Board Member
- June Lee, M.D. Board Member